RxDoctor Payments Data

William Respess, DPM

Foot & Ankle Surgery · Greenville, NCNPI 1063401164

Payments from drug & device makers

What this record shows

This record is dominated by other: $78,247 of the $79,336 with a category attached, or 98.6%. Linvatec Corporation accounts for 98.6% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2022 at $69,327 and has fallen 99.9% since, to $51 in 2025. Among foot & ankle surgery clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$79,336in general payments, 2019–2025

Across 32 payments — averaging $2479.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Linvatec Corporation$78K
  • Amgen$495
  • In2bones USA, LLC$256
  • Arthrosurface Incorporated$176
  • Organogenesis Inc.$40
  • Globus Medical$36
  • plus $85 from 6 others

What the payments were for

  • Food & beverage$1,0891%
  • Other$78,24799%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$79,336 in reported general payments places this provider in the 95th percentile of 196 foot & ankle surgery providers in North Carolina.

See all foot & ankle surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$869,122
Medicare patients
345
Services billed
2,406

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Colchicine43$2,353
Ciclopirox65$1,927
Cephalexin126$1,257
Allopurinol209$1,218
Ketoconazole50$969
Gabapentin125$956
Linezolid15$765
Terbinafine Hcl63$546
Doxycycline Hyclate68$525
Pregabalin34$425
Meloxicam135$391
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav29$282
Clindamycin Hcl32$232
Prednisone25$194
Levofloxacin20$183

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Greenville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →